BGNE

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

BeiGene (BGNE) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

BGNE is expected to report earnings to rise 874.67% to -87 cents per share on March 26

Q4'24

Est.

$-0.88

Q3'24

Beat

by $0.95

Q2'24

Beat

by $1.04

Q1'24

Beat

by $0.51

Q4'23

Beat

by $0.01

The last earnings report on November 12 showed earnings per share of -9 cents, beating the estimate of -103 cents. With 50.08K shares outstanding, the current market capitalization sits at 19.97B.

View a ticker or compare two or three

Compare

BGNE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For BGNE
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for BGNE (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

c/o Mourant Governance Services (Cayman) Limited

Phone

+1 345 949-4123

Employees

10600

Web

https://www.beigene.com